SEC Company Response from Histogen Inc. (CIK 0001383701) — Dec 29, 2020
Histogen Inc. (CIK 0001383701)
Date: Dec. 29, 2020 · CIK: 0001383701 · Accession: 0001193125-20-328875
AI Filing Summary & Sentiment
File numbers found in text: 333-251491
Letter
December 29, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.,
Mail Stop 3030
Washington, D.C. 20549
Attention: Jason L. Drory
Re: Histogen Inc.
Registration Statement on Form S-1
File No. 333-251491
Acceleration Request
Requested Date:
Wednesday, December 30, 2020
Requested Time:
5:15 P.M. Eastern Standard Time,
or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Histogen Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement at 5:15 p.m., EDT, on Wednesday, December 30, 2020 or as soon thereafter as practicable.
Please notify Larry W. Nishnick of DLA Piper LLP (US), counsel to the Company, at (858) 677-1414 once the Registration Statement has been declared effective. Thank you for your assistance with this filing.
Very truly yours,
HISTOGEN INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 29, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E., Mail Stop 3030 Washington, D.C. 20549 Attention: Jason L. Drory Re: Histogen Inc. Registration Statement on Form S-1 File No. 333-251491 Acceleration Request Requested Date: Wednesday, December 30, 2020 Requested Time: 5:15 P.M. Eastern Standard Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Histogen Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement at 5:15 p.m., EDT, on Wednesday, December 30, 2020 or as soon thereafter as practicable. Please notify Larry W. Nishnick of DLA Piper LLP (US), counsel to the Company, at (858) 677-1414 once the Registration Statement has been declared effective. Thank you for your assistance with this filing. Very truly yours, HISTOGEN INC. /s/ Richard W. Pascoe Richard W. Pascoe Chief Executive Officer and President cc: Larry W. Nishnick, DLA Piper LLP (US)